The Behavior Change for Good Initiative (BCFG) at the Wharton School and the School of Arts & Sciences of the University of Pennsylvania, in collaboration with […]
The U.S. Food and Drug Administration approved the first therapy in its class to reduce the frequency of bone marrow suppression induced by chemotherapy for extensive-stage […]
Some research has shown that ultra-fit athletes such as marathon runners can have cardiac damage such as heart scarring or arrhythmia, raising the question of whether […]